EyePoint (EYPT) Total Current Liabilities (2011 - 2026)

EyePoint (EYPT) posted Total Current Liabilities of $37.5 million for Q1 2026, up 1.18% sequentially from $37.0 million in Q4 2025, and down 10.12% YoY from $41.7 million in Q1 2025.

EyePoint (EYPT) Total Current Liabilities (2011 - 2026) Analysis & Trends

EyePoint has reported Total Current Liabilities for 16 years, with the latest figure at $37.5 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 10.12% year-over-year to $37.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.5 million (down 10.12% YoY) and the FY2025 annual result came in at $37.0 million, down 24.51% from the prior year.
  • Total Current Liabilities climbed to $37.5 million in Q1 2026 per EYPT's latest filing, from $37.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $68.9 million in Q2 2023 and troughed at $27.2 million in Q1 2023.
  • A 5-year average of $44.7 million and a median of $37.5 million in 2026 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities soared 137.86% in 2022, then slumped 46.58% in 2025.
  • Over 5 years, Total Current Liabilities stood at $34.5 million in 2022, then jumped by 83.17% to $63.3 million in 2023, then retreated by 22.47% to $49.0 million in 2024, then decreased by 24.51% to $37.0 million in 2025, then gained by 1.18% to $37.5 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $37.5 million, $37.0 million, and $30.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 EyePoint 1.25 Bn 1.07 Bn 507,000.00 41.94 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 41.94 Mn
Mar 31, 2026 37.46 Mn
Dec 31, 2025 37.02 Mn
Sep 30, 2025 30.09 Mn
Jun 30, 2025 33.18 Mn
Mar 31, 2025 41.68 Mn
Dec 31, 2024 49.05 Mn
Sep 30, 2024 48.79 Mn
Jun 30, 2024 62.10 Mn
Mar 31, 2024 62.58 Mn
Dec 31, 2023 63.26 Mn
Sep 30, 2023 63.90 Mn
Jun 30, 2023 68.92 Mn
Mar 31, 2023 27.24 Mn
Dec 31, 2022 34.54 Mn
Sep 30, 2022 34.26 Mn
Jun 30, 2022 33.39 Mn
Mar 31, 2022 31.97 Mn
Dec 31, 2021 23.66 Mn
Sep 30, 2021 19.93 Mn